中国当代医药Issue(21)：92-93,96,3.
阿立哌唑和利培酮治疗首发精神分裂症的效果分析
Effect analysis of aripiprazole and risperidone in the treatment of first-episode schizophrenia
颜晓章 1何美群 1陈文英1
作者信息
- 1. 江西省吉安市第三人民医院，江西吉安 343000
- 折叠
摘要
Abstract
Objective To study the clinical effect between aripiprazole and risperidone in the treatment of first-episode schizophrenia. Methods 85 cases of first-episode schizophrenia patients in our hospital from January 2011 to January 2013 were randomly divided into two groups.The control group was treated with risperidone while the observation group was given aripiprazole treatment.Then the clinical effect and drug adverse reaction between two groups was compared respectively. Results After the treatment,the total effective rate of the treatment of observation group was 91.30%.While the total effective rate of control group was 92.31%,with no statistical differenc (P>0.05).The incidence of adverse reac-tions of observation group was 26.09%, while the control group was 69.23%,with statistical difference (P<0.05). Con-clusion The clinical effect of aripiprazole and risperidone in the treatment of first-episode schizophrenia is significant, but the adverse reaction of aripiprazole is smaller and the safety is higher.It is worthy of clinical popularization and ap-plication.关键词
精神分裂症/阿立哌唑/利培酮Key words
Schizophrenia/Aripiprazole/Risperidone分类
医药卫生引用本文复制引用
颜晓章,何美群,陈文英..阿立哌唑和利培酮治疗首发精神分裂症的效果分析[J].中国当代医药,2015,(21):92-93,96,3.
